Citation

Alice M Stek, Edmund V Capparelli, Chengcheng Hu, Sandra K Burchett, Steven S Rossi, Elizabeth Hawkins, Michael Basar, Elizabeth Smith, Jennifer S Read, IMPAACT 1026s Study Team, Mark Mirochnick, Brookie M Best. Atazanavir pharmacokinetics with and without tenofovir during pregnancy. Journal of Acquired Immune Deficiency Syndromes. 2011. 56: 412-419. PMID: 21283017

Citation

Hepatitis B Vaccination in HIV-Infected Youth: A Randomized Trial of Three Regimens. Journal of Acquired Immune Deficiency Syndromes. 2011. 56: 325-332. PMID: 21350366

Citation

Medication Adherence in Youth with HIV Infection: Associations with Behavioral Impairment. AIDS Patient Care and STDs. 2011. 25: 191-200. PMID: 21323533

Citation

Avy Violari, Soyeon Kim, Mark Cotton, Raziya Bobat, Patrick Jean-Philippe, George McSherry, Charles Mitchell, P1041 Study Team, Shabir A Madhi, Sharon Nachman. Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children. New England Journal of Medicine. 2011. 365: 21-31. PMID: 21732834

Citation

Long-term Outcomes for HIV-Infected Infants <6 Months of Age at Initiation of Lopinavir/Ritonavir Combination Antiretroviral Therapy. AIDS. 2011. 25: 643-9. PMID: 21297419

Citation

Steady-State Pharmacokinetics of Tenofovir Based Regimens in HIV-Infected Pediatric Patients. Antimicrobial Agents and Chemotherapy. 2011. 55: 4290-4. PMID: 21670182

Citation

Clinical Management and Follow-up of Hypercholesterolemia Among Perinatally HIV-Infected Children Enrolled in the PACTG 219C Study. Journal of Acquired Immune Deficiency Syndromes. 2011. 57: 413-420. PMID: 21602698

Citation

Safety and Immunogenicity of Early Measles Vaccination in Children Born to HIV Infected Mothers: Results of Pediatric AIDS Clinical Trials Group (PACTG). Journal of Infectious Diseases. 2011. 2011: S179-S189. PMID: 21666159

Citation

Pharmacokinetics and Safety of a New Pediatric Fixed-Dose-Combination of Zidovudine/Lamivudine/Nevirapine Compared to the Original Liquid Formulations in HIV-infected Children. Journal of Acquired Immune Deficiency Syndromes. 2011. 2011: 2040-2058. PMID: 22155910

Citation

Lynda Harper, Linda Harrison, Michael Hughes, Ross McKinney, Ann Melvin, Lynne Mofenson, Yacine Saidi, M Elizabeth Smith, Gareth Tudor-Williams, PENPACT-1 (PENTA 9/PACTG 390) Study Team, A Sarah Walker, Abdel Babiker, Hannah Castro nee Green, Alexandra Compagnucci, Susan Fiscus, Carlo Giaquinto, Diana M Gibb. First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial. Lancet Infectious Diseases. 2011. 11: 278-83. PMID: 21288774